GABAergisen tartunnan GM1-säätely: toiminnalliset vaikutukset hippokampuksen toimintaan ja epileptogeneesiin

Rahoitetun hankkeen kuvaus

In world 50 millions of people suffering for epilepsy which is very disabling disease. One possible explanation of this disease is an imbalance between excitatory/inhibitory systems in brain, triggered by dysregulation in chloride homeostasis. In neurons, chloride homeostasis is modulated by several proteins, including the co-transporter KCC2. In epilepsy, the expression and functionality of KCC2 are altered contributing to the severity of the disease. A good therapeutic strategy to treat epilepsy would be to target KCC2 and improve its functionality. Hovewer, the lack of knowledge on its intrinsec properties and on its mecanisms of regulation complicate its specific and efficient targeting. My researches, lead at Neuroscience Center at Univeristy of Helsinki, will evaluate on animal models of epilepsy and human tissue ressections, how GM1, a lipid membrane interacting with KCC2, modulate this co-transporter. The emphasis will be to correlate molecular data with functional alterations.
Näytä enemmän

Aloitusvuosi

2020

Päättymisvuosi

2025

Myönnetty rahoitus

Coralie DI SCALA Orcid -palvelun logo
438 874 €

Muut päätökset

335956
Akatemiatutkijan tutkimuskulut(2020)
299 993 €

Rahoittaja

Suomen Akatemia

Rahoitusmuoto

Akatemiatutkijan tehtävä

Muut tiedot

Rahoituspäätöksen numero

333096

Tieteenalat

Neurotieteet

Tutkimusalat

Molekyyli- ja solutason neurotiede

Tunnistetut aiheet

brain, neuroscience